Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Trummel, C.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trummel, C.L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Regulation of Oral Chemotherapeutic Products in the United States

C.L. Trummel

Department of Periodontology, School of Dental Medicine, University of Connecticut Health Center, Farmington, CT 06030

Although many countries have well-established mechanisms for regulation of drugs dispensed by prescription order, far less attention has been directed to control of drugs sold "over-the-counter" (OTC). Since most oral chemotherapeutic agents are OTC preparations, these drugs frequently escape critical review of their safety and efficacy by regulatory agencies. Although widespread use of these OTC preparations indicates that they are generally safe, their effectiveness is not established. In some cases (e.g., detergent pre-brush rinses), there is good evidence for lack of efficacy. In the US, two recent developments suggest that more rigorous scientific review and oversight of oral chemotherapeutic agents will occur. First, the US Food & Drug Administration has initiated a process to evaluate several OTC products which claim to be effective against plaque and gingivitis. A panel of experts has been convened to establish criteria by which these products will be judged and regulated. The agency has also publicly indicated its intention to interact more closely with the dental community in discharging its responsibility for ensuring drug safety and eff icacy. Second, the American Dental Association, through its Council on Dental Therapeutics, is refining criteria for evaluating various types of chemotherapeutic agents. These criteria will be used to judge the efficacy and safety of agents voluntarily submitted for review to the Council by manufacturers. Both of these developmentsshould improve the clinical utility of suchagents and may provide models for regulatory agencies in other countries.

Key Words: Drug Regulation • Drug Safety • Efficacy.

REFERENCES

  • Apple W. (1992). What do consumers want? J Publ Hlth Dent 62:379-382.
  • Council on Dental Therapeutics (1984). Accepted dental therapeutics. 40th ed. Chicago: American Dental Association.
  • Council on Dental Therapeutics (1986). Guidelines for acceptance of chemotherapeutic products for the control of supragingival dental plaque and gingivitis. J Am Dent Assoc 112:529-532.[Medline] [Order article via Infotrieve]
  • " FDA orders halt to some gingivitis claims" (1988). American Dental Association News 19:1.
  • Horowitz HS (1992). A researcher's view. J Publ Hlth Dent 52:383-386.
  • Jacob J. (1990). "FDA requests data on plaque, gingivitis aids." American Dental Association News 21:5.
  • " New ways to save your teeth" (1989). Consumer Reports 54:504-509.
  • Nielsen JR (1986). Handbook of Federal drug law. Philadelphia: Lea & Febiger.
  • Over-the-counter dental and oral health care drug products for antiplaque use; safety and efficacy review (1990). Federal Register 55:38560-38562.
  • Palmer C. (1993). "FDA Chief seeks closer communication with ADA." American Dental Association News 24(5):12.
  • Temin P. (1980). Taking your medicine. Drug regulation in the United States. Cambridge, MA: Harvard University Press.
  • Walters PG (1992). FDA's new drug evaluation process: A general overview. J Publ Hlth Dent 52:333-337.
  • Whall CW (1992). The how and why of the ADA's evaluation program for dental therapeutic products. J Publ Hlth Dent 52:338-342.

Journal of Dental Research, Vol. 73, No. 3, 704-708 (1994)
DOI: 10.1177/00220345940730031701


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Trummel, C.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trummel, C.L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?